[go: up one dir, main page]

NL8204626A - Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen. - Google Patents

Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen. Download PDF

Info

Publication number
NL8204626A
NL8204626A NL8204626A NL8204626A NL8204626A NL 8204626 A NL8204626 A NL 8204626A NL 8204626 A NL8204626 A NL 8204626A NL 8204626 A NL8204626 A NL 8204626A NL 8204626 A NL8204626 A NL 8204626A
Authority
NL
Netherlands
Prior art keywords
afp
ibuprofen
activity
muco
inflammative
Prior art date
Application number
NL8204626A
Other languages
English (en)
Dutch (nl)
Original Assignee
Ausonia Farma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ausonia Farma Srl filed Critical Ausonia Farma Srl
Publication of NL8204626A publication Critical patent/NL8204626A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL8204626A 1982-03-10 1982-11-29 Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen. NL8204626A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2007382 1982-03-10
IT20073/82A IT1190727B (it) 1982-03-10 1982-03-10 Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
NL8204626A true NL8204626A (nl) 1983-10-03

Family

ID=11163583

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8204626A NL8204626A (nl) 1982-03-10 1982-11-29 Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen.

Country Status (14)

Country Link
US (1) US4501914A (xx)
JP (1) JPS58162554A (xx)
BE (1) BE895111A (xx)
CH (1) CH650491A5 (xx)
DE (1) DE3242961C2 (xx)
ES (1) ES8401009A1 (xx)
FR (1) FR2523124B1 (xx)
GB (1) GB2116541B (xx)
GR (1) GR77030B (xx)
IT (1) IT1190727B (xx)
LU (1) LU84486A1 (xx)
NL (1) NL8204626A (xx)
PT (1) PT75894B (xx)
ZA (1) ZA827898B (xx)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212840B (it) * 1983-11-28 1989-11-30 Zambeletti Spa L Derivati di acidi bifenililalcanoici, loro preparazione e composizioni farmaceutiche che licontengono.
US9303038B2 (en) 2011-09-06 2016-04-05 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological diseases
WO2013168021A1 (en) 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
CN104350041A (zh) 2012-05-07 2015-02-11 塞利克斯比奥私人有限公司 用于治疗神经系统疾病的组合物和方法
WO2013167990A1 (en) 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of depression
US9522884B2 (en) 2012-05-08 2016-12-20 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic disorders
WO2013168023A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of parkinson's disease
US9403826B2 (en) 2012-05-08 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory disorders
WO2013167993A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological degenerative disorders
US20150133533A1 (en) * 2012-05-08 2015-05-14 Mahesh Kandula Compositions and methods for the treatment of cough
WO2013168025A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for treatment of blood clotting disorders
US9499526B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of neurologic diseases
WO2013167999A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurologic diseases
WO2013168011A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of chronic pain
US9403857B2 (en) 2012-05-10 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9499527B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of familial amyloid polyneuropathy
US9233161B2 (en) 2012-05-10 2016-01-12 Cellix Bio Private Limited Compositions and methods for the treatment of neurological conditions
US9242939B2 (en) 2012-05-10 2016-01-26 Cellix Bio Private Limited Compositions and methods for the treatment of respiratory disorders
US9315478B2 (en) 2012-05-10 2016-04-19 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
WO2013168005A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
WO2013168000A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of severe pain
US9394288B2 (en) 2012-05-10 2016-07-19 Cellix Bio Private Limited Compositions and methods for the treatment of asthma and allergy
US9346742B2 (en) 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
US9321775B2 (en) 2012-05-10 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of moderate to severe pain
WO2013175344A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9227974B2 (en) 2012-05-23 2016-01-05 Cellex Bio Private Limited Compositions and methods for the treatment of respiratory disorders
SG11201407326XA (en) 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of mucositis
AU2013264896A1 (en) 2012-05-23 2014-11-27 Cellixbio Private Limited Compositions and methods for the treatment of multiple sclerosis
SG11201407319YA (en) 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of inflammatory bowel disease
WO2013175376A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of local pain
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
US9187427B2 (en) 2012-08-03 2015-11-17 Cellix Bio Private Limited N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
US9624168B2 (en) 2012-09-06 2017-04-18 Cellix Bio Private Limited Compositions and methods for the treatment inflammation and lipid disorders
AU2013311349A1 (en) 2012-09-08 2014-11-27 Cellixbio Private Limited Compositions and methods for treatment of inflammation and lipid disorders
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
AU2014276346A1 (en) 2013-06-04 2015-12-24 Cellixbio Private Limited Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
US10227301B2 (en) 2015-01-06 2019-03-12 Cellix Bio Private Limited Compositions and methods for the treatment of inflammation and pain
WO2016046835A1 (en) 2014-09-26 2016-03-31 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological disorders
CN107207403A (zh) 2014-09-29 2017-09-26 塞尔利克斯生物私人有限公司 用于治疗多发性硬化的组合物和方法
SG11201703369WA (en) 2014-10-27 2017-05-30 Cellix Bio Private Ltd Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
US9932294B2 (en) 2014-12-01 2018-04-03 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150137A (en) * 1975-12-24 1979-04-17 Hisamitsu Pharmaceutical Co. Inc. Pyridylalkyl esters of 2-(p-isobutylphenyl)acetic acid and propionic acids and use
IT1064751B (it) * 1976-07-09 1985-02-25 Acraf P. isobutil idratropato di guaiacolo

Also Published As

Publication number Publication date
ES517685A0 (es) 1983-12-16
CH650491A5 (it) 1985-07-31
DE3242961C2 (de) 1984-05-10
JPH0121139B2 (xx) 1989-04-19
IT1190727B (it) 1988-02-24
FR2523124A1 (fr) 1983-09-16
US4501914A (en) 1985-02-26
FR2523124B1 (fr) 1985-07-19
ZA827898B (en) 1983-08-31
ES8401009A1 (es) 1983-12-16
IT8220073A0 (it) 1982-03-10
PT75894B (en) 1986-01-15
LU84486A1 (fr) 1983-06-13
PT75894A (en) 1982-12-01
GR77030B (xx) 1984-09-04
JPS58162554A (ja) 1983-09-27
DE3242961A1 (de) 1983-09-15
GB2116541A (en) 1983-09-28
GB2116541B (en) 1985-10-02
BE895111A (nl) 1983-03-16

Similar Documents

Publication Publication Date Title
NL8204626A (nl) Nieuwe verbinding met analgetische, ontstekingsremmende en muco-regulerende activiteit, de bereiding daarvan en verwante farmaceutische verbindingen.
KR100546038B1 (ko) 항염증및항혈전성활성을지닌새로운화합물및그조성물
JP2745436B2 (ja) フェニルアルカン酸誘導体、その製造方法並びにその光学異性体の分離方法
JPH03500889A (ja) キノリン誘導体
PL188649B1 (pl) Kompozycje farmaceutyczna do leczenia chorób, w których mediatorem jest cyklooksygenaza-2, zawierająca 3-fenylo-4-(4-(metylosulfonylo)fenylo)-2(5H)-furanon oraz zastosowanie 3-fenylo-4-(4-(metylosulfonylo)fenylo)-2(5H)-furanonu
EP0163270A2 (en) A lipoxygenase inhibitor
KR970011460B1 (ko) 디-3급-부틸페놀 화합물의 사이클릭 유도체 및 이를 포함하는 약제학적 조성물
US9351980B2 (en) Di-aspirin derivatives
WO1987002891A1 (en) Compounds and method for the topical treatment of inflammation and pain
JPH0222271A (ja) 共役γ−オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤
JPS58201713A (ja) 製薬組成物およびその製造方法
JPS631286B2 (xx)
CN115974925B (zh) 一种甲状腺激素受体β激动剂及其应用
EP1505986A1 (en) COMBINATION OF AN HMG-CoA REDUCTASE INHIBITOR AND A NITRATE ESTER
JPS5973516A (ja) 抗炎症剤
JPS6183125A (ja) 癌転移阻害剤
JPS60248611A (ja) 動脈硬化用剤
EP0091995A1 (en) New compound having antiinflammatory, analgesic and mucoregulating activity, process for its production and relative pharmaceutical compositions
Singh et al. Anti-inflammatory activity of some traditional medicinal plants
EP0440098A1 (en) Optically active derivative of d-2-(6-methoxy-2-naphthyl)-propionic acid and pharmaceutical compositions containing it
JPH0723366B2 (ja) 新規なフラン化合物及びその製造法
SU869267A1 (ru) N-[4-(3,3-Диметилтриазено)-фенилсульфонил]-изовалериламид, про вл ющий противовоспалительное действие
US4435591A (en) Compound with analgesic, antiinflammatory and antipyretic activity, and pharmaceutical compositions therefrom
CH639072A5 (en) 2-[ alpha -(p-Chlorophenoxy)isobutyrate] of 2,6-pyridinedimethanol and process for its preparation
CS260735B1 (cs) Monoglyceridy arylpropionových kyselin

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed